PETALING JAYA: The demand for private healthcare will continue to gain traction in 2024 with the growing patient throughput and higher yields from a case-mix with more acute cases, says Kenanga Research.
The sector will be aided by better operational efficiencies, cost optimisation and overhead absorption with a gradual ramp-up of new beds, besides robust sales of pharmaceuticals and over-the-counter (OTC) drugs backed by increased health awareness, the research house added.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
